Regulations.gov document
Guidance for Clinical Investigators, Institutional Review Boards and Sponsors; Process for…
Other · FDA-2006-D-0032 · posted Dec 1, 2006
Key facts
| Document ID | FDA-2006-D-0032-0006 |
|---|---|
| Title | Guidance for Clinical Investigators, Institutional Review Boards and Sponsors; Process for Handling Referrals to FDA Under 21 CFR 50.54; Additional Safeguards for Children in Clinical Investigations |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2006-D-0032 |
| Posted | Dec 1, 2006 |
| Comment period opens | Dec 1, 2006 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: